243 results
424B3
OCUP
Ocuphire Pharma Inc
16 Feb 24
Prospectus supplement
4:31pm
of our common stock to decline. A substantial majority of the outstanding shares of our common stock are, and the shares of common stock offered hereby
8-K
EX-10.1
29wlrxxr
5 Dec 23
Departure of Directors or Certain Officers
7:15pm
8-K
EX-99.1
6dat3b3 l52a
2 Nov 23
Ocuphire Corporate Presentation November 2023
8:44am
8-K
EX-10.1
savux77
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
424B5
fnkws6
14 Aug 23
Prospectus supplement for primary offering
8:00am
8-K
EX-10.1
ol2u72
11 Aug 23
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
9:27am
8-K
EX-99.1
kmkblh24 gd03
1 Aug 23
Restore Vision & Clarity Ocuphire Corporate Presentation August 2023
11:21am
8-K
2uuj5tnh
8 Jun 23
Submission of Matters to a Vote of Security Holders
5:58pm
8-K
i9f9968jr28
2 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-3.1
peul c9a5m5b
2 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.2
psvvqvav1s17
15 May 23
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
8:07am